Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism mGluR5 modulators(Metabotropic glutamate receptor 5 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H9ClN6O2 |
InChIKeyUEUUWJVQGWZIJY-UHFFFAOYSA-N |
CAS Registry1620203-63-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | United States | 01 Aug 2014 |